Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

AbbVie Inc.’s disappointing trial results for its new schizophrenia drug bode well for rival Bristol Myers Squibb Co., ...

Here is her moving account of how she has learnt to live with schizophrenia... To be honest, I can¿t remember when I first heard the voices. They have certainly been there at least since my late ...

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...

We’re moving people out of the criminal justice system instead of into it, we’re saving resources, we’re saving taxpayer ...

Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a new study finds poor attention spans in childhood, plus certain ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

This image provided by Bristol Myers Squibb in October 2024 shows the company's drug Cobenfy, which the U.S. Food and Drug Administration approved for the treatment of schizophrenia in September 2024.